Patents by Inventor Hitoshi Zembutsu

Hitoshi Zembutsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETERMINING SIDE EFFECTS OF TRASTUZUMAB AND KIT FOR SAME
    Publication number: 20220154259
    Abstract: A side effect of trastuzumab is predicted by using a gene polymorphism associated with the side effect of trastuzumab. The genotype of a gene polymorphism specified by one selected from the group consisting of rs9316695, rs11932853, rs28415722, rs7406710 and rs8032978 is determined and a side effect from administration of trastuzumab is determined based on the genotype determined.
    Type: Application
    Filed: March 6, 2020
    Publication date: May 19, 2022
    Applicants: Tokyo Kohan Co., Ltd, Japanese Foundation For Center Research
    Inventors: Hitoshi Zembutsu, Chihiro Unagawa, Mari Nakano
  • METHOD FOR CONFIRMING PRDM14 EXPRESSION
    Publication number: 20210208148
    Abstract: One embodiment of this invention is a method for confirming expression of the PRDM14 gene from blood or lymphatic fluid collected from a subject by: (1) detecting PRDM14 positive CTC which expresses the PRDM14 gene; or (2) measuring the concentration of at least one protein selected from the group consisting of leptin receptor (LEPR), macrophage-derived chemokine (MDC) and gamma-interferon (IFN?).
    Type: Application
    Filed: September 25, 2018
    Publication date: July 8, 2021
    Applicants: The University of Tokyo, Kanagawa Prefectural Hospital Organization
    Inventors: Kohzoh Imai, Hitoshi Zembutsu, Hiroaki Taniguchi, Anri Saitoh, Yohei Miyagi